Aswin Mangerich
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Physiology top 2%
- Calcium signaling and nucleotide metabolism
Papers in
- Oncology 38
- PARP inhibition in cancer therapy 37
-
- DNA Repair Mechanisms 21
- Co-authors
- Alexander Bürkle (33 shared papers)Sebastian Veith (8 shared papers)Annika Krüger (7 shared papers)Karin Hauser (4 shared papers)Peter C. Dedon (5 shared papers)Arthur Fischbach (10 shared papers)James G. Fox (3 shared papers)Gerald N. Wogan (3 shared papers)
- Journals
- Nucleic Acids Research (9 papers)Archives of Toxicology (7 papers)Toxicology Letters (4 papers)Proceedings of the National Academy of Sciences (3 papers)Cells (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Aswin Mangerich
59 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 130
- Oncology 775
- Physiology 131
- Aging 49
- Geriatrics and Gerontology 67
- Molecular Biology 981
Countries citing papers authored by Aswin Mangerich
This map shows the geographic impact of Aswin Mangerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aswin Mangerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aswin Mangerich more than expected).
Fields of papers citing papers by Aswin Mangerich
This network shows the impact of papers produced by Aswin Mangerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aswin Mangerich. The network helps show where Aswin Mangerich may publish in the future.
Co-authors
The 25 scholars most cited alongside Aswin Mangerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 209 | |
| 2 | 2013 | 97 | |
| 3 | 2012 | 91 | |
| 4 | 2017 | 88 | |
| 5 | 2021 | 76 | |
| 6 | 2018 | 74 | |
| 7 | 2020 | 72 | |
| 8 | 2010 | 66 | |
| 9 | 2014 | 59 | |
| 10 | 2010 | 55 | |
| 11 | 2020 | 54 | |
| 12 | 2021 | 50 | |
| 13 | 2020 | 47 | |
| 14 | 2020 | 45 | |
| 15 | 2014 | 43 | |
| 16 | 2012 | 41 | |
| 17 | 2021 | 40 | |
| 18 | 2013 | 39 | |
| 19 | 2013 | 39 | |
| 20 | 2014 | 32 |
About Aswin Mangerich
Aswin Mangerich is a scholar working on Oncology, Molecular Biology, Plant Science, Electrical and Electronic Engineering and Health, Toxicology and Mutagenesis, having authored 61 papers that have together received 1.9k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (37 papers), DNA Repair Mechanisms (21 papers), Integrated Circuits and Semiconductor Failure Analysis (9 papers), Pesticide Exposure and Toxicity (6 papers), Electrostatic Discharge in Electronics (5 papers), Carcinogens and Genotoxicity Assessment (5 papers), Calcium signaling and nucleotide metabolism (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). The work is most often cited by research in Oncology (775 citations), Physiology (131 citations), Aging (49 citations), Geriatrics and Gerontology (67 citations) and Molecular Biology (981 citations). Aswin Mangerich has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Alexander Bürkle, Sebastian Veith, Annika Krüger, Karin Hauser, Peter C. Dedon, Arthur Fischbach, James G. Fox, Gerald N. Wogan, Steven R. Tannenbaum and Erin G. Prestwich. Their work appears in journals such as Nucleic Acids Research, Archives of Toxicology, Toxicology Letters, Proceedings of the National Academy of Sciences and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.